eFFECTOR Therapeutics (EFTR) PEG Ratio
Market Cap: $941
Avg Volume: 918
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- eFFECTOR Therapeutics's trailing twelve month (TTM) PEG ratio is 0.00.
- eFFECTOR Therapeutics's annual PEG ratio as of today is -0.01.
- eFFECTOR Therapeutics's quarterly PEG ratio is 0.05.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess eFFECTOR Therapeutics's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -0.71
- Quarterly: -1.81
- TTM: 0.00
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 0.00
- Quarterly: 0.00
- TTM: 0.01
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: -4.41
- Quarterly: 77.34
- TTM: 0.00
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -0.87
- Quarterly: -8.79
- TTM: 0.00
These metrics provide insights into eFFECTOR Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
0.00
Annual PEG Ratio
-0.01
Quarterly PEG Ratio
0.05
eFFECTOR Therapeutics Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
eFFECTOR Therapeutics Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2023 | -0.01 | -0.71 | 0.00 | -4.41 | -0.87 |
| 2022 | 0.01 | -1.36 | 4.96 | 4.52 | -0.68 |
| 2021 | -0.36 | 21.17 | 233.87 | 19.35 | -13.44 |
| 2020 | -0.07 | 10.48 | 3.55 | -1.13 | 10.76 |
| 2019 | 0.00 | -4.62 | 0.00 | -9.93 | -4.98 |
Related Metrics
Explore detailed financial metrics and analysis for EFTR.